|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H.B. 1287
|
|
VETOES
|
|
|
|
|
|
|
|
|
|
|
|
|
(3) AN OUTCOME OR CARE THAT RESULTS IN AN UNANTICIPATED
CONSEQUENCE; OR
(4) (III) CORRECTIVE ACTION, IF APPROPRIATE.
(2) IF A RESIDENTIAL TREATMENT CENTER SENDS A NOTICE TO AN
INDIVIDUAL UNDER PARAGRAPH (1) OF THIS SUBSECTION. THE INDIVIDUAL MAY
SEND A WRITTEN RESPONSE TO THE RESIDENTIAL TREATMENT CENTER
INSTRUCTING THE RESIDENTIAL TREATMENT CENTER THAT:
(I) THE INDIVIDUAL WAIVES THE NOTIFICATION REQUIRED
UNDER PARAGRAPH (1) OF THIS SUBSECTION; OR
(II) THE INDIVIDUAL ONLY REQUIRES NOTIFICATION UNDER THE
CIRCUMSTANCES SPECIFIED IN WRITING BY THE INDIVIDUAL.
(C) A RESIDENTIAL TREATMENT CENTER SHALL DOCUMENT THE
NOTIFICATION REQUIRED UNDER SUBSECTION (B)(1) OF THIS SECTION AND THE
RESPONSE OF THE RESIDENT AND THE RESIDENTS REPRESENTATIVE, FAMILY
MEMBER, LEGAL GUARDIAN, OR CUSTODIAN IN THE RESIDENT'S MEDICAL RECORD.
(D) IF THE DEPARTMENT DETERMINES THAT A RESIDENTIAL TREATMENT
CENTER FAILED TO NOTIFY A RESIDENT AND A RESIDENTS REPRESENTATIVE,
FAMILY MEMBER, LEGAL GUARDIAN, OR CUSTODIAN UNDER SUBSECTION (B)(1) OF
THIS SECTION, THE DEPARTMENT SHALL REQUIRE THE RESIDENTIAL TREATMENT
CENTER, AS PART OF A PLAN OF CORRECTION, TO NOTIFY THE RESIDENT AND THE
RESIDENTS REPRESENTATIVE, FAMILY MEMBER, LEGAL GUARDIAN, OR CUSTODIAN
AS SOON AS POSSIBLE.
SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect
October 1, 2006.
|
|
|
|
|
|
|
|
|
|
May 26, 2006
The Honorable Michael E. Busch
Speaker of the House
State House
Annapolis, MD 21401
Dear Mr. Speaker:
In accordance with Article II, Section 17 of the Maryland Constitution, today I have
vetoed House Bill 1287 - Prescription Drug Monitoring Program.
This bill requires the Department of Health and Mental Hygiene (DHMH), in
consultation with a newly established Advisory Board on Prescription Drug
Monitoring, to establish a centralized prescription drug monitoring program that
electronically collects and stores data concerning controlled prescription drugs.
Pharmacists dispensing Schedule I through IV controlled substances in the State
would be required to submit to the program data regarding each prescription
including the date and quantity of the drug dispensed, the prescribing physician, and
a patient identifier.
- 3818 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
